vs
Amarin Corp plc（AMRN）与Clipper Realty Inc.（CLPR）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是Clipper Realty Inc.的1.2倍（$45.1M vs $37.1M），Amarin Corp plc净利率更高（-23.3% vs -30.4%，领先7.1%），Amarin Corp plc同比增速更快（7.0% vs -2.6%），过去两年Clipper Realty Inc.的营收复合增速更高（1.8% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
AMRN vs CLPR — 直观对比
营收规模更大
AMRN
是对方的1.2倍
$37.1M
营收增速更快
AMRN
高出9.6%
-2.6%
净利率更高
AMRN
高出7.1%
-30.4%
两年增速更快
CLPR
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $37.1M |
| 净利润 | $-10.5M | $-11.3M |
| 毛利率 | — | -5.2% |
| 营业利润率 | 35.5% | 21.8% |
| 净利率 | -23.3% | -30.4% |
| 营收同比 | 7.0% | -2.6% |
| 净利润同比 | 33.0% | -938.6% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCLPR
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $37.1M | ||
| Q3 25 | $49.7M | $37.7M | ||
| Q2 25 | $72.7M | $39.0M | ||
| Q1 25 | $42.0M | $39.4M | ||
| Q4 24 | $62.3M | $38.0M | ||
| Q3 24 | $42.3M | $37.6M | ||
| Q2 24 | $67.5M | $37.3M |
净利润AMRNCLPR
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $-11.3M | ||
| Q3 25 | $-7.7M | $-4.6M | ||
| Q2 25 | $-14.1M | $-1.4M | ||
| Q1 25 | $-15.7M | $-35.1M | ||
| Q4 24 | $-48.6M | $-1.1M | ||
| Q3 24 | $-25.1M | $-1.1M | ||
| Q2 24 | $1.5M | $-1.7M |
毛利率AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | -5.2% | ||
| Q3 25 | 44.7% | 23.6% | ||
| Q2 25 | 69.2% | 27.8% | ||
| Q1 25 | 59.8% | -34.5% | ||
| Q4 24 | -15.4% | 28.8% | ||
| Q3 24 | 38.5% | 28.6% | ||
| Q2 24 | 63.4% | 26.8% |
营业利润率AMRNCLPR
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 21.8% | ||
| Q3 25 | -22.4% | 23.6% | ||
| Q2 25 | -22.0% | 27.7% | ||
| Q1 25 | -39.9% | -59.9% | ||
| Q4 24 | -84.3% | 28.1% | ||
| Q3 24 | -59.5% | 28.6% | ||
| Q2 24 | -0.8% | 26.8% |
净利率AMRNCLPR
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | -30.4% | ||
| Q3 25 | -15.6% | -12.2% | ||
| Q2 25 | -19.4% | -3.5% | ||
| Q1 25 | -37.4% | -89.1% | ||
| Q4 24 | -78.0% | -2.9% | ||
| Q3 24 | -59.4% | -2.9% | ||
| Q2 24 | 2.3% | -4.7% |
每股收益（稀释后）AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | — | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.03 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.12 | — | ||
| Q3 24 | $-0.06 | — | ||
| Q2 24 | $0.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $30.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $-30.7M |
| 总资产 | $645.8M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNCLPR
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $30.8M | ||
| Q3 25 | $286.6M | $26.1M | ||
| Q2 25 | $298.7M | $32.0M | ||
| Q1 25 | $281.8M | $21.3M | ||
| Q4 24 | $294.2M | $19.9M | ||
| Q3 24 | $305.7M | $18.6M | ||
| Q2 24 | $306.7M | $20.3M |
总债务AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.2B |
股东权益AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $-30.7M | ||
| Q3 25 | $458.9M | $-25.0M | ||
| Q2 25 | $464.9M | $-21.9M | ||
| Q1 25 | $473.7M | $-20.1M | ||
| Q4 24 | $486.2M | $-5.4M | ||
| Q3 24 | $531.4M | $-3.6M | ||
| Q2 24 | $551.9M | $-1.8M |
总资产AMRNCLPR
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $1.2B | ||
| Q3 25 | $659.8M | $1.2B | ||
| Q2 25 | $670.1M | $1.2B | ||
| Q1 25 | $655.7M | $1.3B | ||
| Q4 24 | $685.3M | $1.3B | ||
| Q3 24 | $750.6M | $1.3B | ||
| Q2 24 | $799.9M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $22.6M | ||
| Q3 25 | $-12.7M | $1.4M | ||
| Q2 25 | $16.6M | $8.4M | ||
| Q1 25 | $-12.5M | $6.7M | ||
| Q4 24 | $-13.3M | $31.9M | ||
| Q3 24 | $-2.4M | $6.3M | ||
| Q2 24 | $-2.7M | $8.8M |
自由现金流AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.6M | ||
| Q4 24 | — | $-37.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -11.7% | ||
| Q4 24 | — | -99.5% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.6% | ||
| Q4 24 | — | 183.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金转化率AMRNCLPR
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
